Please don't Wake Me: One Million People to be Screened for Risky Sleep Disorder

Royal Philips ElectronicsSnore much? Beware: it's one of the key signs of a disorder that may lead to serious chronic diseases, including diabetes or heart disease. In an effort to help obstructive sleep apnea (OSA) sufferers identify and combat the disorder, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) will screen one million people worldwide for OSA over the next five years.

Philips' program, consistent with its stated commitment to improve access to health care and save lives, will include screening across North America, Europe and Asia. The program uses an online risk assessment on its World Sleep Day website. Individuals who have symptoms or believe they may be at-risk are encouraged to take the online risk assessment test. Upon completion, it will provide their risk level for OSA and encourage follow up with their health care provider.

"Obstructive sleep apnea steals health from its sufferers and put them on a path to potentially life-threatening diseases," said Brent Shafer, CEO, Philips Home Healthcare Solutions. "It is our goal to use our innovative solutions to help OSA sufferers identify and combat this very serious disorder."

Obstructive sleep apnea is one of the most common sleep disorders, and affects approximately five to six percent of the adult population. It is characterized by a narrowing or closing of the upper airway, which hinders breathing during sleep.

Sleep is often labeled as the 'third pillar of good health', along with diet and exercise. Philips research suggests that more than two-thirds of all people with sleep apnea are not diagnosed.

The most common cause of obstructive sleep apnea is weight gain. Other signs and symptoms of sleep apnea include:

  • Frequent loud snoring
  • Pauses in breathing or gasping for breath
  • Obesity
  • Regularly falling asleep in situations, such as reading, watching TV or driving
  • High blood pressure

"There are three important steps to helping individuals with OSA: awareness, diagnosis and treatment. Each is integral to improving the sleep quality and overall health of individuals around the world," said Dr. Lee-Chiong, chief medical liaison for Philips Home Healthcare Solutions. "Philips' pledge helps individuals take the first step to make them aware of their risk for OSA."

About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 118,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming, home and portable entertainment and oral healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...